Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000303 · ClinicalTrials.gov registry record · Phase 2
Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
A Phase 2 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000303 is a Phase 2 study that has completed, run by University of California, Los Angeles.
The verdict
NCT00000303, a Phase 2 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to empirically test a series of medications to: 1) determine each medication's efficacy in treatment of cocaine abuse/dependence; 2) find most effective dose range for each medication. In this study, baclofen is tested.
Interventions
- DRUG Baclofen
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000303
The ClinicalTrials.gov registry entry for NCT00000303 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Baclofen is the first listed.
NCT00000303 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000303 about?
NCT00000303 is a clinical study titled "Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6". The purpose of this study is to empirically test a series of medications to: 1) determine each medication's efficacy in treatment of cocaine abuse/dependence; 2) find most effective dose range for each medication. In this study, baclofen is tested.
What is the current status of trial NCT00000303?
This trial is currently completed. It is a Phase 2 study. The study started on 1997-10.
What interventions are being tested in trial NCT00000303?
The interventions under investigation include: Baclofen (DRUG).
Who is sponsoring clinical trial NCT00000303?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.